Werbung

Joint Polish Investment Fund Management (JPIF) has announced the first closing of its new venture capital fund, Joined Polish Investment Fund I at 42 Mio. USD (38,7 Mio. EUR). It is the first institutional venture capital fund operating out of Poland that is completely dedicated to life science investments. The fund will invest in promising Central and Eastern European Life Science companies.

The fund will invest in early- and mid-stage companies with a close relationship to Poland and marks an important milestone on the country’s path to further strengthen its life science industry. Investment activities will focus on areas with strong growth, relatively short holding periods and high return potential e.g. companies in the area of medical technology, enabling technology or mobile health.

JPIF I is backed and supported by The National Centre for Research and Development (NCBR). NCBR is an executive agency of the Ministry of Science and Higher Education of Poland and supports national science as well as general innovation policies.

 

Über den Autor

Die GoingPublic Redaktion informiert über alle Börsengänge, Being Public, Investor Relations, Tax & Legal, Themen und Trends rund um die Hauptversammlung sowie Technologie – Finanzierung – Investment in den Lebenswissenschaften.